Ali, Seemaab <br/><br/>
CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice.  [electronic resource] 

 -  Aging  02 2020 
 - 2101-2122 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1945-4589 
<br/><br/><label>Standard No.: </label>10.18632/aging.102724  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue--drug effects<br/>Aging--metabolism<br/>Animals<br/>Body Composition--drug effects<br/>Body Weight--drug effects<br/>Brain-Derived Neurotrophic Factor--drug effects<br/>Corticotropin-Releasing Hormone--drug effects<br/>Female<br/>Glial Fibrillary Acidic Protein--drug effects<br/>Glucose Tolerance Test<br/>Gonadotropin-Releasing Hormone--drug effects<br/>Housing, Animal<br/>Hypothalamus--drug effects<br/>Inflammation--genetics<br/>Macrophages--drug effects<br/>Mice<br/>Microglia--drug effects<br/>Neuropeptide Y--drug effects<br/>Organic Chemicals--pharmacology<br/>Pro-Opiomelanocortin--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Receptors, Granulocyte-Macrophage Colony-Stimulating Factor--antagonists & inhibitors<br/>Social Environment<br/>Transcriptome--drug effects<br/>Weight Loss